SNAQ Launches AI-Powered Glucose Prediction feature

by christoph | Mar 20, 2025 | Innovation, Press Release, Research

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing diabetes care.

The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.

SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the company’s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.

For more details, read the full press release or visit SNAQ’s website to learn more about their innovations in diabetes care.

More recent news

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

1 · Apr · 2025 | Innovation, Research

For the fifth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically...

SNAQ Launches AI-Powered Glucose Prediction feature

20 · Mar · 2025 | Innovation, Press Release, Research

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing...

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

13 · Mar · 2025 | Innovation

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused...

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

info@dcberne.com

Impressum

Datenschutzerklärung

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

by christoph | Mar 13, 2025 | Innovation

Back to News

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused research, as featured in the special issue of Finanz und Wirtschaft.

DCB in Finanz und Wirtschaft special

A unique aspect of DCB is its close collaboration with the diabetes community, integrating their needs and experiences into research and development processes. DCB also partners with international research and industry organizations to enhance healthcare efficiency and improve the quality of life for people with diabetes.

On the right, you can download the entire article in German.

Downloads

Finanz und Wirtschaft 3 / 2025

PDF

More recent news

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

1 · Apr · 2025 | Innovation, Research

For the fifth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically...

SNAQ Launches AI-Powered Glucose Prediction feature

20 · Mar · 2025 | Innovation, Press Release, Research

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing...

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

13 · Mar · 2025 | Innovation

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused...

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

info@dcberne.com

Impressum

Datenschutzerklärung

Meet us at ATTD!

by Carlotta Bilger | Mar 13, 2025 | Innovation

Back to News

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

19-22 MARCH 2025 AMSTERDAM, NETHERLANDS-2

DCB at ATTD 2025

The ATTD (Advanced Technologies & Treatments in Diabetes) congress is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Amsterdam fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.

We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with, you!

Also, we are excited to participate in ATTD Ignite 2025, an exclusive platform designed to foster innovation and collaboration in diabetes technology. This event, taking place on March 19, 2025, from 09:00 to 13:00 in Hall C, provides a unique opportunity for startups and researchers to connect, share insights, and accelerate breakthroughs in diabetes care. Greta Ehlers, Business Scouting & Development at DCB, will be speaking in the session “Empowering Startups for Success” from 09:05 to 10:00, where key topics such as funding strategies, pitch refinement, and global expansion will be discussed. Don’t miss this opportunity to gain valuable insights and engage with industry experts!

If you are attending ATTD and are eager to learn more about our services, the Open Innovation Challenge, our main research areas, our community, or any other topics – please reach out to those attending and book a coffee slot. We look forward to connecting with you!

Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls for after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.

Downloads